相关实验视频
Updated: May 8, 2026

12:23
Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
10.4K
纳塔利祖马布治疗多发性硬化症患者的皮肤质性病:一个病例报告
Kosar Kohandel1, Sara Ala1, Banafshe Tamizifar1
1Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
BMC neurology
|April 2, 2025
概括
皮肤炎 (PG) 是一种罕见的皮肤疾病. 一名接受纳塔利祖马布 (NTZ) 治疗的患者发展了PG,在停止NTZ后恢复,这表明可能存在药物诱导的联系.
科学领域:
- 免疫皮肤学 免疫皮肤学
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 炎症性皮肤病 (PG) 是一种免疫媒介的炎症性皮肤病.
- PG呈现为痛苦的性,并与诸如风湿性关节炎 (RA) 和炎症性肠病 (IBD) 等全身性疾病有关.
- 单克隆抗体治疗也与PG发生率有关.
研究的目的:
- 在患有多发性硬化症 (MS) 的患者中报告可能由纳塔利祖马布 (NTZ) 治疗诱导的Pyoderma Gangrenosum (PG) 病例.
- 调查NTZ治疗和PG的发展之间的关系.
- 强调在PG病例中考虑药物诱导病因的重要性.
主要方法:
- 一个38岁的MS患者长期接受纳塔利祖马布 (NTZ) 治疗的病例报告.
- 在NTZ剂量后肌痛,发烧和疼痛的皮肤病变的临床表现.
- 通过综合测试和MRI排除其他全身性疾病和MS复发.
- 皮肤病学咨询,皮肤活检和PG的组织病理学确认.
- 在停止NTZ治疗后观察病变愈合.
主要成果:
- 患者在第十五剂NTZ后出现了与PG一致的症状.
- 排除了全身性疾病和MS复发的可能性.
- 皮肤活检证实了Pyoderma Gangrenosum的存在.
- 病变在停止NTZ治疗后显著改善和愈合,没有特殊的皮肤病治疗.
结论:
- 这一案例表明,纳塔利祖马布 (NTZ) 治疗与皮肤病 (PG) 的发展之间存在潜在的联系.
- 暂停NTZ导致PG病变的自发愈合,支持药物诱导的病因.
- 这个案例增加了对PG与特定单克隆抗体治疗的关联的理解.
相关概念视频
Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Nephrotic Syndrome II : Assessment and Medical Management
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Nephrotic Syndrome III : Nursing Management
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

